Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @BioprocessIC
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @BioprocessIC
-
Behnam Ahmadian, Global Head of Process Development at Lonza, discusses the scaling of manufacturing, process development challenges,
#automation and the latest#technologies for#cell therapies in this exclusive interviewhttps://youtu.be/E5kVbsLhQvUHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CAR-T and T-cell receptor
#cell therapies are some of the most exciting emerging therapies on the market today. This whitepaper discusses recent developments in CAR and TCR#engineering and the overlap with#antibody engineeringhttps://informaconnect.com/tcr-car-t-cell-therapies-engineering-strategies-whitepaper/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How are leading biotech and pharma organizations successfully implementing
#DiversityandInclusion initiatives? Here are 6 best practices chosen by Edie Stringfellow@MassBio#BiotechWeekBoston http://spr.ly/60101585M pic.twitter.com/6q6ZwEv4qJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
On the road to successful
#antibody discovery, the search for validated targets becomes more challenging. This whitepaper examines the latest innovations addressing the current practical challenges in antibody discovery. http://spr.ly/6010158ku pic.twitter.com/lTRaos4i2i
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
When developing a new therapy how do you keep in complete control of its manufacturing? This whitepaper looks at what to consider - whatever path you take.http://spr.ly/601915rtT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
62% of respondents
#manufacture their cell and#gene therapies both internally and externally http://spr.ly/60151585R pic.twitter.com/DydOyg0FBy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How can you navigate the regulatory maze to get peptide, oligonucleotide and mRNA therapies to market? This whitepaper presents successful strategies & case studies. http://spr.ly/6015158nN pic.twitter.com/8ckyITcuUf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Viral vector vaccines hold great promise for confronting new, complex pathogens. Three
#bioprocessing industry experts discuss the challenges of manufacturing viral vector#vaccines in this@BioProcessIntl eBookhttps://informaconnect.com/viral-vectors-vaccines-production-analysis/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bioprinting is ready to create tissue products with high commercial and therapeutic value, but there are still key development hurdles to make the
#technology viable for the#biopharmaceutical industryhttps://informaconnect.com/bioprinting-capabilities-futures/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As the search for validated targets becomes more challenging, unconventional strategies are becoming more significant. This whitepaper examines the latest innovations and current practical challenges in
#antibody discovery https://get.informaconnect.com/antibody-engineering/wp-optimizediscovery/ …pic.twitter.com/IwSTofvRjo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Authors from GSK and MockV Solutions describe the use of a noninfectious
#virus particle as an economical spiking surrogate in this@BioProcessIntl deep divehttps://informaconnect.com/modeling-virus-clearance/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The high costs of
#CART cell therapy puts it out of reach for many cancer patients. How can it be made more affordable? We asked three industry experts http://spr.ly/6018158ZM pic.twitter.com/cTWxFmjF7w
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Heidelberg-based
@NCT_HD have created tumor-targeted oncolytic virus vaccines using encoded bispecific T-cell engagers. In this recorded webinar, Christine Engeland, MD, PhD explains their journey.http://spr.ly/6013158kxHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What’s the recipe for getting peptide, oligonucleotide and mRNA treatments approved? This whitepaper explores how to navigate the current regulatory frameworks.http://spr.ly/6014158VY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess International’s editors share their experiences of the 2019 BPI US conference in Boston, focusing attention on elements that are driving
#innovation in the#biopharmaceutical industryhttps://informaconnect.com/2019-bioprocess-international-event-report/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Behnam Ahmadian, Global Head of Process Development at Lonza, discusses the scaling of manufacturing, process development challenges,
#automation and the latest#technologies for#cell therapies in this exclusive interviewhttps://youtu.be/E5kVbsLhQvUHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How are leading biotech and pharma organizations successfully implementing
#DiversityandInclusion initiatives? Here are 6 best practices chosen by Edie Stringfellow@MassBio http://spr.ly/6014158mg#BiotechWeekBostonpic.twitter.com/ee2TsWYuaF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess International managing editor Maribel Rios rounds up the latest technologies that demonstrate the bioprocessing industry’s dedication to finding new ways to help manufacturers shorten time to markethttps://informaconnect.com/technology-highlights-from-bioprocess-international-2019/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As the search for validated targets becomes more challenging, unconventional strategies are becoming more significant. This whitepaper examines the latest innovations and current practical challenges in
#antibody discovery https://get.informaconnect.com/antibody-engineering/wp-optimizediscovery/ …pic.twitter.com/6YWBvwlC2i
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Can viruses be used to create tumor-targeted vaccines? In an on-demand webinar, Christine Engeland, MD, PhD
@NCT_HD explains how they have done just that, by encoding bispecific T-cell engagers within measles virus vectors. http://spr.ly/6019158WN pic.twitter.com/h4XXTtYCrN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.